Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 25, 2014 - Issue 1
Submit an article Journal homepage
402
Views
8
CrossRef citations to date
0
Altmetric
Systemic treatments

Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial

M. Elaine HusniCleveland Clinic, Cleveland, OH, USACorrespondence[email protected]
,
Abrar A. QureshiBrigham and Women's Hospital, Boston, MA, USA
,
Andrew S. KoenigPfizer Inc., Collegeville, PA, USA
,
Ronald PedersenPfizer Inc., Collegeville, PA, USA
&
Deborah RobertsonPfizer Inc., Collegeville, PA, USA
Pages 90-95 | Received 22 Mar 2013, Accepted 03 Apr 2013, Published online: 20 Jun 2013

References

  • Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53:573.
  • Taylor WJ. Epidemiology of psoriatic arthritis. Curr Opin Rheumatol. 2002;14:98–103.
  • Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009;23:683–691.
  • Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040–1047.
  • Gladman DD, Brockbank J. Psoriatic arthritis. Expert Opin Investig Drugs. 2000;9:1511–1522.
  • Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4:441–447.
  • Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63:1091–1097.
  • Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61:233–239.
  • Williams JP, Meyers JA. Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs. Am J Manag Care. 2002;8:S664–SS81; quiz S82-S5.
  • Thumboo J, Uramoto K, Shbeeb MI, O'Fallon WM, Crowson CS, Gibson LE, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002;29:757–762.
  • Qureshi AA, Husni ME, Mody E. Psoriatic arthritis and psoriasis: need for a multidisciplinary approach. Semin Cutan Med Surg. 2005;24:46–51.
  • Dominguez PL, Husni ME, Holt EW, Tyler S, Qureshi AA. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res. 2009;301:573–579.
  • Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol. 2007;57:581–587.
  • Van Voorhees A, Feldman SR, Koo JYM, Lebwohl MG, Menter A. The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment algorithms and management options. 3rd edition Portland, Oregon: The National Psoriasis Foundation; 2009. 3rd. http://www.psoriasis.org/document.doc?id=354. Cited 2013 12 February.
  • Strohal R, Puig L, Chouela E, Tsai TF, Melin J, Freundlich B, et al. The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in patients with moderate-to-severe psoriasis (the PRISTINE trial). J Dermatolog Treat. 2013;24:169–178.
  • Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283–298.
  • Zou KH, Liu AI, Bandos AI, Ohno-Machado L, Rockette H. Chapter 1. Background and Introduction. In: Chapman E, Hall W, editors. Statistical evaluation of diagnostic performance: topics in ROC analysis. Chapman & Hall/CRC Biostatistics Series Boca Raton, FL: Chapman & Hall/CRC, 2011.
  • Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–2673.
  • Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68:664–667.
  • Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009;68:497–501.
  • Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27:469–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.